Ellevest, Inc. Prometheus Biosciences, Inc. Transaction History

Ellevest, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$103.46 - $126.29 $4,862 - $5,935	47 Added 391.67%	59 $6,000
Q4 2022 Feb 03, 2023	BUY	$36.06 - $117.21 $144 - $468	4 Added 50.0%	12 $1,000
Q3 2022 Nov 02, 2022	SELL	$28.17 - $59.01 $112 - $236	-4 Reduced 33.33%	8 $0
Q2 2022 Jul 18, 2022	BUY	$22.39 - $38.94 $268 - $467	12 New	12 $0

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.